Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer

[1] Bleiberg H(1998)Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer Semin Oncol 25 32-39

[2] de Gramont A(1998)Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer Semin Oncol 25 23-31

[3] Becouarn Y(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947

[4] Rougier P(2002)Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Semin Oncol 29 21-33

[5] De Gramont A(2005)Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer BMC Cancer 16 116-392

[6] Figer A(2004)Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy Muscle Nerve 29 387-1263

[7] Seymour M(1994)Diseases associated with excess motor unit activity Muscle Nerve 17 1250-701

[8] Gamelin E(2000)Neuromyotonia in mice with hereditary myelinopathies Muscle Nerve 23 696-1465

[9] Gamelin L(1979)Penicillamine-induced neuromyotonia BMJ 1 1464-529

[10] Bossi L(1988)Gold neurotoxicity and myokymia J Rheumatol 15 528-234

[1] Bleiberg H(1998)Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer Semin Oncol 25 32-39

[2] de Gramont A(1998)Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer Semin Oncol 25 23-31

[3] Becouarn Y(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947

[4] Rougier P(2002)Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Semin Oncol 29 21-33

[5] De Gramont A(2005)Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer BMC Cancer 16 116-392

[6] Figer A(2004)Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy Muscle Nerve 29 387-1263

[7] Seymour M(1994)Diseases associated with excess motor unit activity Muscle Nerve 17 1250-701

[8] Gamelin E(2000)Neuromyotonia in mice with hereditary myelinopathies Muscle Nerve 23 696-1465

[9] Gamelin L(1979)Penicillamine-induced neuromyotonia BMJ 1 1464-529

[10] Bossi L(1988)Gold neurotoxicity and myokymia J Rheumatol 15 528-234